Outlook Therapeutics Inc (OTLK)

[H2R]

Sounds like they'll need to raise funds before EoY:

At June 30, 2021, Outlook Therapeutics had cash and cash equivalents of $19.7 million. Outlook Therapeutics’ cash and cash equivalents on hand are sufficient to fund planned operations through December 2021.

https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeutics-reports-financial-results-third-quarter-0

This may actually be a good buying opportunity. I've seen lots of raises initially push the PPS down, only to move back up within a few days.

Given the state of the company (post TLD, de-risked), they should be able to raise funds on fairly good terms.

Best of luck with your investments.